Stock Movers: Jefferies' Profit Drop, AbbVie Denies Revolution Acquisition, Raytheon's Trump-Related Volatility

Jefferies Financial Group Performance

• 📉 Jefferies shares experienced declines after reporting a mixed bag of quarterly results, including an EPS miss.
• ⚠️ A significant factor contributing to the disappointing profit was a $30 million pre-tax loss linked to the collapse of auto-parts supplier First Brands Group.
• 📊 Despite the profit miss, net revenue saw a year-over-year increase, and capital markets/investment banking showed strong growth.

AbbVie and Revolution Medicines Deal Rumors

• 🚫 AbbVie has officially stated it is not in talks to acquire cancer drug maker Revolution Medicines, despite earlier reports suggesting advanced negotiations.
• 💰 Revolution Medicines' shares initially surged on the acquisition rumors, which suggested a potential deal worth $20 billion.
• 🎯 An acquisition would have provided AbbVie a foothold in the pancreatic cancer market, projected to grow significantly by 2035.

Raytheon and Defense Stocks React to Trump Comments

• 🗣️ President Trump criticized Raytheon (RTX), calling it the "least responsive" to the Department of Defense's needs and threatening to cut ties.
• 📉 Shares of Raytheon and other defense contractors like Northrop Grumman, Lockheed Martin, and General Dynamics saw declines following these comments.
• 📈 However, Raytheon's stock showed signs of recovery, trading up after hours, indicating market volatility around the news.